Home›Research›Compare›5-Amino-1MQ vs Eloralintide
Peptide Comparison5-Amino-1MQ vs Eloralintide
Both are Metabolic peptides.
5-Amino-1MQ
5-Amino-1-methylquinolinium
51 providers listed
Eloralintide
LY3841136
Half-life: Not published
1 providers listed
Eloralintide carries stronger published evidence (Meta-analysis, 4 key studies) than 5-Amino-1MQ (Animal, 1); both are research compounds.
5-Amino-1MQ
Eloralintide
| Your goal | Better option |
|---|---|
| Stronger clinical evidence | Eloralintide |
| Further along in FDA review | Eloralintide |
| Oral administration option | 5-Amino-1MQ |
| More provider options (51 vs 1) | 5-Amino-1MQ |
Research summary only — not medical advice. Consult a qualified provider before making any decisions.
5-Amino-1MQ
Eloralintide
Eloralintide
Novel Amylin-Based Therapies for Weight Management in Adults With Overweight or Obesity Without Diabetes: A N…
Eloralintide, a selective, long-acting amylin receptor agonist for treatment of obesity: Phase 1 proof of con…
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentr…
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to cli…
About 5-Amino-1MQ
Inhibits NNMT enzyme, increasing SAM (S-adenosylmethionine) availability. Alters adipocyte gene expression to reduce fat cell size and may increase brown adipose tissue activity via epigenetic mechanisms.
About Eloralintide
Selective long-acting amylin receptor agonist; preferentially activates AMY1R over the calcitonin receptor to prolong satiety and slow gastric emptying
Information below reflects published research data only — not medical advice. Consult a qualified provider before use.
5-Amino-1MQ
No established clinical contraindications. This is an investigational compound with limited human data and has not been evaluated by the FDA for safety in this context. Consult a qualified clinician.
Eloralintide
Under clinical review
Being verified by our medical team before we display contraindications for this peptide.
No amylin-specific monitoring protocol is established for eloralintide, which remains investigational and is available only through clinical trials. Trial programmes track a baseline metabolic panel covering glycaemic markers, renal and hepatic function, and lipase. Calcitonin and TSH are carried over from incretin-class convention rather than from any eloralintide-specific signal, as the compound is designed for reduced calcitonin receptor activity.
5-Amino-1MQ
Eloralintide
Not enough vendor pricing yet.
Where to source these peptides
5-Amino-1MQ
51 listed
Browse directory →
Providers offeringEloralintide
1 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More Metabolic Comparisons
Browse all peptides →Educational research tools — not medical advice.
Cite this page
Data last updated August 26, 2026
Free to reference and republish with attribution to PeptideBase. Choose a format:
PeptideBase. (2026). 5-Amino-1MQ vs Eloralintide — Per-mg Price Comparison. Retrieved September 12, 2026, from https://peptidebase.io/peptides/compare/5-amino-1mq/eloralintide